Copyright
©The Author(s) 2017.
World J Gastroenterol. Mar 21, 2017; 23(11): 2023-2028
Published online Mar 21, 2017. doi: 10.3748/wjg.v23.i11.2023
Published online Mar 21, 2017. doi: 10.3748/wjg.v23.i11.2023
Table 1 Baseline characteristics of patients
| Ipilimumab induced enterocolitis | Ipilimumab without enterocolitis | |
| Demographics | ||
| Total number of patients | 16 | 98 |
| Mean age in years | 63 | 61 |
| Female sex, n (%) | 8 (50) | 28 (29) |
| Laboratory characteristics prior to ipilimumab | ||
| Mean white blood cell count, cells/cu. mm (range) | 6720 (3510-17100) | 7530 (1080-25800) |
| Reference range 4500-11000 cells/cu. mm | ||
| Mean lymphocyte count, cells per cu. mm (range) | 1570 (592-4610) | 1440 (97-4420) |
| Reference range 1150-4800 cells/cu. mm | ||
| Mean neutrophil count, cells per cu. mm (range) | 4350 (2040-11610) | 5200 (668-23500) |
| Reference range 1800-7000 cells/cu. mm |
- Citation: Jain A, Lipson EJ, Sharfman WH, Brant SR, Lazarev MG. Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis. World J Gastroenterol 2017; 23(11): 2023-2028
- URL: https://www.wjgnet.com/1007-9327/full/v23/i11/2023.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i11.2023